Welcome to our dedicated page for Sanuwave Health SEC filings (Ticker: SNWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sanuwave Health’s SEC documents can feel like you’re decoding clinical trial data and FDA nuances at the same time. Whether you’re tracing reimbursement risk in a 300-page annual report or scanning for new device revenue in a 10-Q, the stakes are high—especially when chronic wound-care adoption drives valuation. That’s why Stock Titan puts AI-powered summaries on every filing, turning dense medical terminology into plain-English takeaways investors can act on.
Searches like “Sanuwave Health quarterly earnings report 10-Q filing” or “Sanuwave Health 8-K material events explained” land you here because we map each question to the right form. Want insider confidence signals? Our platform streams Sanuwave Health Form 4 insider transactions real-time, flags option exercises, and keeps a historical log under “Sanuwave Health executive stock transactions Form 4.” Need the bigger picture? The Sanuwave Health annual report 10-K simplified section highlights device pipeline progress, R&D spend, and regulatory milestones. For governance detail, the “Sanuwave Health proxy statement executive compensation” tab breaks out PACE-based performance metrics without the legal clutter.
Every filing—from routine “Sanuwave Health insider trading Form 4 transactions” to surprise 8-K updates—is indexed seconds after EDGAR posts. Our AI spots shifts in wound-care reimbursement language, compares quarter-over-quarter revenue, and attaches concise context so you can stop scrolling and start deciding. If you’ve ever typed “understanding Sanuwave Health SEC documents with AI” or looked for “Sanuwave Health earnings report filing analysis,” you’ve just found the place investors rely on for clarity, speed, and total coverage.
Jeffrey Blizard, a company director of SANUWAVE Health, Inc. (SNWV), reported the acquisition of 1,342 shares of common stock through the exercise of a stock option on 09/30/2025. The option had an exercise price of $37.48 and the underlying shares are exercisable through 09/30/2030. The filing states the options were fully vested at grant date and lists the transaction as a direct ownership change. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Ian D. Miller, a director of SANUWAVE Health, Inc. (SNWV), reported a Form 4 showing the acquisition on 09/30/2025 of 1,510 stock options with an exercise price of $37.48. The options were reported as fully vested at grant and are exercisable beginning 09/30/2025 with an expiration of 09/30/203010/02/2025. The filing lists the reporting person’s address in Eden Prairie, MN and indicates the Form was filed by one reporting person.
SANUWAVE Health, Inc. filed a Form S-8 to register securities for an employee benefit plan and states the registration statement is currently effective. The filing incorporates by reference the company’s Annual Report for the year ended December 31, 2024, Quarterly Reports for the quarters ended March 31, 2025 and June 30, 2025, numerous Current Reports filed in 2025, and the Form 8-A description of Common Stock. Part I disclosure documents are not filed here but will be delivered to plan participants as permitted by rule.
Solas Capital Management, LLC and Frederick Tucker Golden report beneficial ownership of 296,691 shares of SANUWAVE Health, Inc. common stock, representing 3.5% of the outstanding shares based on 8,555,616 shares outstanding as of May 5, 2025. The filing clarifies that Solas acts as an investment adviser to private funds and Mr. Golden, as portfolio manager, shares voting and dispositive power over these shares.
The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Both Solas and Mr. Golden report no sole voting or dispositive power and shared voting and dispositive power over all 296,691 shares.
SANUWAVE Health, Inc. (SNWV) filed an Form 8-K dated 8-Aug-2025 under Item 2.02 to furnish—not file—a press release announcing its financial results for the quarter ended 30-Jun-2025. The detailed numbers are contained in Exhibit 99.1, which is not reproduced in the body of this report. Management will host a business-update conference call on 8-Aug-2025 at 8:30 a.m. EST; supporting materials are available on the investor section of the company’s website. The filing also lists Exhibit 104, which embeds the cover-page XBRL tags, and confirms that the information is excluded from Section 18 liability and is not incorporated by reference into other Securities Act filings.
FAQ
What is the current stock price of Sanuwave Health (SNWV)?
What is the market cap of Sanuwave Health (SNWV)?
